中国中西医结合急救杂志
中國中西醫結閤急救雜誌
중국중서의결합급구잡지
INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE IN PRACTICE OF CRITICAL CARE MEDICINE
2001年
3期
156-157
,共2页
肾综合征出血热%黄芪注射液%参麦注射液
腎綜閤徵齣血熱%黃芪註射液%參麥註射液
신종합정출혈열%황기주사액%삼맥주사액
目的：观察黄芪注射液合参麦注射液对肾综合征出血热（HFRS）患者各期的影响。方法：将36例HFRS患者分为黄芪注射液合参麦注射液治疗组（19例）及对照组（17例）。分别于发热期在西药治疗基础上给予黄芪注射液合参麦注射液或单纯西药治疗。结果：治疗组越低血压休克期(94.74％)、越少尿期率(94.74%)，均明显多于对照组（分别为64.71％和58.82％，P均<0.05）；治疗组多尿期、尿素氮、蛋白尿持续时间〔分别为（4.14±3.11）日，(6.17±3.45)日和(5.14±3.45)日〕与对照组〔分别为(7.15±2.81）日，(10.13±4.19）日和(9.56±4.43)日〕比较明显缩短，P均<0.01。结论：黄芪注射液合参麦注射液可加强HFRS患者的抗病能力，减少休克期、少尿期发生率，缩短其它各期发病时间，最终缩短病程。
目的：觀察黃芪註射液閤參麥註射液對腎綜閤徵齣血熱（HFRS）患者各期的影響。方法：將36例HFRS患者分為黃芪註射液閤參麥註射液治療組（19例）及對照組（17例）。分彆于髮熱期在西藥治療基礎上給予黃芪註射液閤參麥註射液或單純西藥治療。結果：治療組越低血壓休剋期(94.74％)、越少尿期率(94.74%)，均明顯多于對照組（分彆為64.71％和58.82％，P均<0.05）；治療組多尿期、尿素氮、蛋白尿持續時間〔分彆為（4.14±3.11）日，(6.17±3.45)日和(5.14±3.45)日〕與對照組〔分彆為(7.15±2.81）日，(10.13±4.19）日和(9.56±4.43)日〕比較明顯縮短，P均<0.01。結論：黃芪註射液閤參麥註射液可加彊HFRS患者的抗病能力，減少休剋期、少尿期髮生率，縮短其它各期髮病時間，最終縮短病程。
목적：관찰황기주사액합삼맥주사액대신종합정출혈열（HFRS）환자각기적영향。방법：장36례HFRS환자분위황기주사액합삼맥주사액치료조（19례）급대조조（17례）。분별우발열기재서약치료기출상급여황기주사액합삼맥주사액혹단순서약치료。결과：치료조월저혈압휴극기(94.74％)、월소뇨기솔(94.74%)，균명현다우대조조（분별위64.71％화58.82％，P균<0.05）；치료조다뇨기、뇨소담、단백뇨지속시간〔분별위（4.14±3.11）일，(6.17±3.45)일화(5.14±3.45)일〕여대조조〔분별위(7.15±2.81）일，(10.13±4.19）일화(9.56±4.43)일〕비교명현축단，P균<0.01。결론：황기주사액합삼맥주사액가가강HFRS환자적항병능력，감소휴극기、소뇨기발생솔，축단기타각기발병시간，최종축단병정。
Objective:To study the influence of astragalus injection(黄芪注射液) plus Shenmai injection(参麦注射液) on each stage of hemorrhagic fever with renal syndrome(HFRS).Methods:Thirty-six cases with HFRS were randomly divided into treated group(n=19) which was treated with western medicine and traditional Chinese medicine (astragalus injection and Shenmai injection) and control group (n=17) which was treated with western medicine alone during fever stage.The curative effects were compared.Results:In treated group the rates of over hypotensive shock stage and over oliguria stage were both 94.74％ ,they were significantly heigher than those in control group(both P<0.05).The prolonged times of polyguria,increased blood urea nitrogen(BUN),and proteinuria in treated group were significantly shorter than those in control group (all P<0.01).Conclusions:The astragalus injection and Shenmai injection possess the ability to enhance the antidisease capability in patient with HFRS and are able to shorten the shock stage,to reduce the occurance rate of oliguria,to shorten the duration of each stage,and finally to shorten ill course and promote the patients to recovery as early as possible.
